ArticleDusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi2026
Psychiatric comorbidities in multiple sclerosis patients and their relationship with clinical variables: A university hospital sample.
Article in Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to determine the prevalence of clinically documented psychiatric diagnoses in patients with multiple sclerosis (MS) and to identify demographic and clinical predictors associated with an increased risk of comorbidity. Method: This study included 382 patients with MS who were followed at a university hospital between January 2022 and June 2025. Medical records were reviewed for demographic characteristics, disease course and duration, disability severity (Expanded Disability Status Scale [EDSS]), comorbid neurological symptoms, disease-modifying therapies, and documented psychiatric diagnoses. Patients were categorized into those with psychiatric comorbidity (PC+) and those without psychiatric comorbidity (PC-). Univariate analyses and binary logistic regression were performed to identify independent predictors. Results: At least one psychiatric diagnosis was present in 35% of the patients. Depression (20%) and anxiety disorders (10%) were the most common conditions. Overall, 51.8% of patients were using at least one psychotropic medication, prescribed either for psychiatric diagnoses or for MS-related symptoms such as fatigue and neuropathic pain. Comparison of the PC+ and PC- groups revealed significant differences in age, sex, duration of MS, disease severity, presence of urinary incontinence, and fatigue. Logistic regression analysis showed that female sex was independently associated with lower odds of psychiatric comorbidity, whereas fatigue, higher EDSS scores, and longer MS duration were associated with higher odds. Conclusion: Psychiatric comorbidities are prevalent in MS, affecting more than one-third of patients. This study comprehensively evaluated the risk factors identified in the literature and found that, when assessed together, most did not remain independent predictors. Key independent predictors for psychiatric comorbidity include female sex, disability severity, disease duration, and fatigue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.